1. Home
  2. FGC vs ATOS Comparison

FGC vs ATOS Comparison

Compare FGC & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FG Communities Holdings Inc. Common Stock

FGC

FG Communities Holdings Inc. Common Stock

N/A

Current Price

$6.06

Market Cap

22.5M

Sector

Finance

ML Signal

N/A

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

N/A

Current Price

$1.93

Market Cap

25.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FGC
ATOS
Founded
N/A
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.5M
25.9M
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
FGC
ATOS
Price
$6.06
$1.93
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $19.00
AVG Volume (30 Days)
61.6K
★ 66.1K
Earning Date
11-06-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $32,023,000.00
$1,758.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 20.70
N/A
52 Week Low
$4.65
$0.53
52 Week High
$7.78
$7.56

Technical Indicators

Market Signals
Indicator
FGC
ATOS
Relative Strength Index (RSI) 50.57 36.59
Support Level $4.97 $1.76
Resistance Level $6.76 $2.60
Average True Range (ATR) 0.69 0.18
MACD 0.14 -0.04
Stochastic Oscillator 61.70 16.09

Price Performance

Historical Comparison
FGC
ATOS

About FGC FG Communities Holdings Inc. Common Stock

FG Communities Holdings Inc, formerly FG Nexus Inc operates through two primary segments: Digital Assets and Merchant Banking, with Digital Assets contributing the majority of revenue. The Company functions as a digital asset treasury, mainly holding Ethereum (ETH) and exploring opportunities in the tokenization of real-world assets, leveraging ETH as the foundation for digital finance, stablecoins, DeFi, and tokenized assets. The Merchant Banking segment offers strategic, administrative, and regulatory support to newly formed SPACs through the Company's SPAC platform.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.

Share on Social Networks: